You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Growth factor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Temporomandibular Joint Disorders Trial in Alexandria (Nd-YAG Fotona, Epidermal Growth Factor)

Enrolling by invitation
  • Temporomandibular Joint Disorders
  • Nd-YAG Fotona
  • Epidermal Growth Factor
  • Alexandria, الإسكندرية, Egypt
    Alexandria University
Sep 13, 2023

Concentrated Growth Factor, Bone Substitute Trial in Haikou (concentrated growth factor, bone substitute, concentrated growth

Recruiting
  • Concentrated Growth Factor
  • Bone Substitute
  • concentrated growth factor
  • +2 more
  • Haikou, Hainan, China
    First Affiliated Hospital of Hainan Medical University
Jul 10, 2023

Brain-derived Neurotrophic Factor Single Nucleotide Gene

Recruiting
  • Allergic Rhinitis
  • Genotyping.
  • Sohag, Egypt
    Sohag university Hospital
Jun 15, 2023

Serum Fibroblast Growth Factor-21 Levels During Prolonged

Completed
  • Fibroblast Growth Factor-21
  • Fasting
  • 12 hour fasting for 29 days
  • Ankara, Turkey
    Hacettepe University Nutrition and Dietetics Department
Mar 29, 2023

Serum Insulin-like Growth Factor Binding Protein-3 asPotential

Not yet recruiting
  • Colorectal Cancer
  • evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
  • (no location specified)
May 6, 2023

Insulin Like Growth Factor-1 Against Oxidative Stress in

Not yet recruiting
  • Vitiligo
  • skin biopsy examined by ELISA technique
  • (no location specified)
Apr 13, 2023

Drug Effect Trial in Tanta (Cinacalcet)

Recruiting
  • Drug Effect
  • Tanta, Egypt
    Sara Mabrouk Mohamed Elghoul
Jun 29, 2023

UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie

Recruiting
  • UVB Phototherapy Burn
  • +2 more
  • Insulin-Like Growth Factor 1
  • No Insulin-Lie Growth Factor 1
  • Fairborn, Ohio
    Wright State Physicians
Jan 9, 2023

Alopecia, Chemo-Induced Change, Hair Loss Trial in Tucson (Keratinocyte growth factor)

Completed
  • Alopecia
  • +3 more
  • Keratinocyte growth factor
  • Tucson, Arizona
    University of Arizona
Dec 15, 2022

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations Trial in

Recruiting
  • Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
  • Canton, Ohio
    Gabrail Cancer and Research Center
Jul 21, 2023

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

Completed
  • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Nov 6, 2023

Nerve Growth Factor Expression in Pediatric Severe Burns:Pilot

Completed
  • Burns
  • pediatric patients affected by severe burns
  • Rome, Italy
    Giorgio Conti
Mar 1, 2023

Peripheral Artery Disease Trial in Chicago (VM202, Placebo)

Recruiting
  • Peripheral Artery Disease
  • Chicago, Illinois
    Northwestern University
Jan 10, 2023

GINGIVAL RECESSION Trial in Tanta (GROUPI, GROUP II)

Completed
  • GINGIVAL RECESSION
  • GROUPI
  • GROUP II
  • Tanta, Egypt
  • +1 more
Mar 21, 2023

Aging Trial in Bangkok (Epidermal Growth Factor)

Active, not recruiting
  • Aging
  • Epidermal Growth Factor
  • Bangkok, Thailand
    Institute of Dermatology
Feb 9, 2023

Dental Implant Failure Nos Trial in Minya (Drug: Growth Factors (CGF), Drug: Growth Factors (PRGF), Surgery: Dental Implant

Recruiting
  • Dental Implant Failure Nos
  • Drug: Growth Factors (CGF)
  • +4 more
  • Minya, Egypt
    Faculty of Dentistry Minia University
Oct 26, 2022

Recurrent Glioblastoma Trial (Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T

Not yet recruiting
  • Recurrent Glioblastoma
  • Targeted Epidermal Growth Factor Receptor Variant III(EGFRvIII) autochimeric antigen receptor T cell injection
  • (no location specified)
Apr 4, 2023

Revascularization Trial (concentrated growth factors in open apex, Blood Clot (BC))

Not yet recruiting
  • Revascularization
  • concentrated growth factors in open apex
  • Blood Clot (BC)
  • (no location specified)
Aug 27, 2023

NSCLC (NSCLC) Trial (Osimertinib, Amivantamab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • (no location specified)
Mar 24, 2023

Fibroblast Growth Factor 21, Tast Perference Trial (Fibroblast growth factor 21 infusion, Placebo infusion (saline))

Active, not recruiting
  • Fibroblast Growth Factor 21
  • Tast Perference
  • Fibroblast growth factor 21 infusion
  • Placebo infusion (saline)
  • Hellerup, Denmark
    Amalie R Lanng
Nov 21, 2022

Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)

Not yet recruiting
  • Optic Pathway Glioma
  • Rome, Italy
    Catholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023

Healthy Volunteers Trial in Strasbourg (Lenograstim)

Recruiting
  • Healthy Volunteers
  • Strasbourg, France
    CHRU Strasbourg
Oct 25, 2022

Perioperative Hemodynamic and Microcirculatory Physiological

Not yet recruiting
  • Aortic Valve Stenosis
  • Determination of arterial compliance using blood pressure waveform analysis
  • +6 more
  • (no location specified)
Dec 1, 2023

Dry Eye Syndrome Trial in Wien (rhNGF 20 µg/mL, rhNGF 4 µg/mL)

Completed
Has Results
  • Dry Eye Syndrome
  • rhNGF 20 µg/mL
  • rhNGF 4 µg/mL
  • Wien, Austria
    Department of Clinical Pharmacology
Dec 14, 2022

Acute Kidney Injury (Nontraumatic), Pneumoperitoneum Trial (IGF-1)

Not yet recruiting
  • Acute Kidney Injury (Nontraumatic)
  • Pneumoperitoneum
  • IGF-1
  • (no location specified)
Nov 8, 2022